Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker LYEL
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2026 | LYEL Lyell Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 10, 2026 | LYEL Lyell Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 6, 2026 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 15, 2026 | LYEL Lyell Immunopharma, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 6, 2026 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 12, 2026 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 9, 2026 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 8, 2025 | LYEL Lyell Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 5, 2025 | LYEL Lyell Immunopharma, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 12, 2025 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 3, 2025 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 16, 2025 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 25, 2025 | LYEL Lyell Immunopharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 25, 2025 | LYEL Lyell Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 25, 2025 | LYEL Lyell Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 26, 2025 | LYEL Lyell Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 17, 2025 | LYEL Lyell Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 9, 2025 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 28, 2025 | LYEL Lyell Immunopharma, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| May 21, 2025 | LYEL Lyell Immunopharma, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 1, 2025 | LYEL Lyell Immunopharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 1, 2025 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 1, 2025 | LYEL Lyell Immunopharma, Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Mar 11, 2025 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 24, 2025 | LYEL Lyell Immunopharma, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Dec 10, 2024 | LYEL Lyell Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 26, 2024 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 7, 2024 | LYEL Lyell Immunopharma, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 31, 2024 | LYEL Lyell Immunopharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 31, 2024 | LYEL Lyell Immunopharma, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 31, 2024 | LYEL Lyell Immunopharma, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Oct 31, 2024 | LYEL Lyell Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 24, 2024 | LYEL Lyell Immunopharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 24, 2024 | LYEL Lyell Immunopharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 24, 2024 | LYEL Lyell Immunopharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 24, 2024 | LYEL Lyell Immunopharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
42 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:10 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances